Oncology and primary care coordination necessary for best cancer patient outcomes
Thanks to new advances in cancer care, more and more people are surviving cancer, with…
Author ONA Editor
ONA Editor
The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.
FDA-approved MI cancer seek test enhances tumour profiling for precision oncology
A new research paper was published in Volume 16 of Oncotarget on August 13, 2025, titled “Clinical…
Breakthrough insights into tumour angiogenesis and endothelial cell origins
This newly published review article offers a comprehensive examination of the complexities of tumour angiogenesis…
CISD1: A multi-faceted cancer biomarker
Despite significant advancements in medicine, cancer remains a major health challenge and the leading cause…
New guidance on the management of aromatase inhibitor-associated bone loss in women with hormone-sensitive breast cancer
An updated joint position statement on the management of aromatase inhibitor-associated bone loss (AIBL) addresses the heightened…
New small-molecule inhibitor could improve treatment options for HCC patients
Researchers from the University of Hong Kong (HKUMed) have made a significant advancement that could…
FDA grants accelerated approval to zongertinib for non-squamous NSCLC with HER2 TKD activating mutations
On August 8, 2025, the Food and Drug Administration granted accelerated approval to zongertinib, a…
Study finds promising new combo therapy for drug-resistant melanoma
A new study may offer a breakthrough for patients with advanced melanoma who don’t respond to…
Unusual case of rare ovarian tumour mimicking pregnancy with successful treatment outcome
A new case report was published in Volume 12 of Oncoscience on July 28, 2025, titled A rare…
Targeting sleeping tumour cells
Neuroblastoma, a cancer mainly affecting children, is often difficult to treat. A team led by…